FDA chief Gottlieb's departure might not actually be a good thing for vaping industry

  • 📰 CNBC
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 72%

Business News News

Business Business Latest News,Business Business Headlines

Some have called FDA Commissioner Scott Gottlieb's resignation a boon for the e-cigarette industry. It may prove more complicated.

Some have called Food and Drug Administration Commissioner Scott Gottlieb's resignation a boon for the e-cigarette industry, which Gottlieb has repeatedly attacked for fueling a surge in teen vaping.

Gottlieb's threats pushed Juul, the company he blames for the teen vaping"epidemic," to halt sales of most of its flavors and shutter its social media accounts. In February, he accused Juul of going back on its word after the San Francisco-based start-up took a $12.8 billion investment from Marlboro maker Altria, and he called the CEOs of both companies to his office.

"He could have [reversed the application extension], he could have tried to pull flavors from the market. So certainly his words were the issue and not always his actions," said Gregory Conley, president of the American Vaping Association, a group that lobbies for"sensible" regulation of vaping products.

"The information on how helpful e-cigarettes are in people trying to quit and how harmful or not they are for young people is a moving target, and it's always hard to set policy in an environment in which you're dealing with one or more moving targets," she said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent. because the new person isn't going to look past the negative health impacts
Source: CNBC - 🏆 12. / 72 Read more »